Evidence map›Paper›PMID 40468084›Full record

ArticleNature2025

Probing condensate microenvironments with a micropeptide killswitch.

Yaotian Zhang, Ida Stöppelkamp, Pablo Fernandez-Pernas, Melanie Allram, Matthew Charman, Alexandre P Magalhaes, Melanie Piedavent-Salomon, Gregor Sommer, Yu-Chieh Sung, Katrina Meyer and 13 more

Abstract read
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Recent Advances in Reactive Microdroplets for Clean Water and Energy.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yaotian ZhangMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0003-3802-0843
Ida Stöppelkamp *Max Planck Institute for Molecular Genetics, Berlin, Germany.
Pablo Fernandez-Pernas *Centre of Biological Sciences, University of Veterinary Medicine, Vienna, Austria.
Melanie Allram *Centre of Biological Sciences, University of Veterinary Medicine, Vienna, Austria.
Matthew Charman *Division of Protective Immunity, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Alexandre P MagalhaesMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-4097-338X
Melanie Piedavent-SalomonMax Planck Institute for Molecular Genetics, Berlin, Germany.
Gregor SommerMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0009-0008-3685-010X
Yu-Chieh SungMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0009-0001-4576-152X
Katrina MeyerMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-8244-6887
Nicholas GramsDepartment of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Edwin HalkoDivision of Protective Immunity, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Shivali DongreCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
David MeierhoferMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-0170-868X
Michal MalszyckiMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0003-1780-5596
Ibrahim A IlikMax Planck Institute for Molecular Genetics, Berlin, Germany.
Tugce AktasMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0003-1599-9454
Matthew L KrausharMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-7359-0318
Nadine VastenhouwCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-8782-9775
Matthew D WeitzmanDivision of Protective Immunity, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Florian GrebienCentre of Biological Sciences, University of Veterinary Medicine, Vienna, Austria.ORCID 0000-0003-4289-2281
Henri NiskanenMax Planck Institute for Molecular Genetics, Berlin, Germany. niskanen@molgen.mpg.de.ORCID 0000-0002-8361-5531
Denes HniszMax Planck Institute for Molecular Genetics, Berlin, Germany. hnisz@molgen.mpg.de.ORCID 0000-0002-6256-1693

Funding

Viral modulation of epitranscriptomic mechanismsR01AI118891 · NIAID · WASHINGTON UNIVERSITY · PI GARCIA, BENJAMIN A, WEITZMAN, MATTHEW D. · 2015 to 2025
$5.4M
Double-stranded RNA during DNA virus infectionR01AI145266 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI WEITZMAN, MATTHEW D. · 2019 to 2023
$3.0M
Adenovirus manipulation of cellular chromatin to overcome host responsesR01AI121321 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI WEITZMAN, MATTHEW D. · 2018 to 2022
$2.7M
NIAID NIH HHS R01 AI118891NIAID NIH HHS R01 AI121321NIAID NIH HHS R01 AI145266
6 · The paper itself

Abstract

Biomolecular condensates are thought to create subcellular microenvironments that have different physicochemical properties compared with their surrounding nucleoplasm or cytoplasm

Indexed as

Biomolecular CondensatesCellular MicroenvironmentPeptidesCapsid ProteinsCell Line, TumorCell NucleolusCell ProliferationHumansHydrophobic and Hydrophilic InteractionsLeukemiaNuclear ProteinsNucleophosminRibosomal ProteinsSingle-Domain AntibodiesCapsid ProteinsNPM1 protein, humanNuclear ProteinsNucleophosminPeptidesRibosomal ProteinsSingle-Domain Antibodies

Identifiers

PMID40468084
PMCPMC12286862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.